Proteomics International has been featured on R&DTI Insights, a podcast from the Australian Governme...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) has signed a distribu...
“The Perth-headquartered company said on Thursday that it has inked a licencing deal with Zotal Ltd ...
“We believe entering both the European and Middle Eastern markets in recent weeks will drive demand ...
“The ability of Proteomics’ PromarkerD to effectively predict kidney disease years in advance has no...
PromarkerD clinical assay platforms successfully validated for reproducibility, robustness and stabi...
“The Federal Government’s R&D tax incentive rebate program is designed to encourage companies to car...
“Throughout FY20, the company spent $2.62 million on R&D, making it eligible for a rebate of $1,138,...
“Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placem...
“We are delighted with the enormous level of support received both from new and existing investors, ...
Funds from the Placement will be used for:
“Previously we focused on the more sophisticated mass spectrometry test, but the release of this eas...
World’s first predictive test for diabetic kidney disease to be made available in Italy in partnersh...
“The two year distribution and licencing agreement was signed with Italian distributor Medical Horiz...
“Proteomics International Laboratories said on Friday that it has signed an agreement for the distri...
“Immunoassays are cost-effective and accurate tests that are standard to clinical diagnostics labora...
“The blood test will help to improve the detection of oesophageal adenocarcinoma, Australia’s most c...
Medical Technology company Proteomics International Laboratories Ltd (Proteomics International; ASX:...
“The partnership between the ASX-listed Proteomics and QIMR Berghofer will see Proteomics deploy its...
Proteomics International partners with QIMR Berghofer Medical Research Institute (QIMR Berghofer) to...
Proteomics International (ASX:PIQ) covered in Small Caps Biotech Stocks video.
“The ability to correctly predict an early decline in kidney function would allow doctors and patien...
“Listen to ASX-listed Proteomics MD, Dr Richard Lipscombe as he chats to Matt Birney on the Bulls N’...
“Having climbed the IP mountain, the focus now for Proteomics is firmly set on revenue generation, w...
PromarkerD secures patents for Brazil and Canada, business model outlined.
“Proteomics International presented results from the study this week in a poster at the Scientific S...
Results of analysis conducted on 3,000 patients from a completed multi-centre clinical trial (the CA...
“A major clinical study involving 3,000 patients has validated ASX-listed Proteomics’ “PromarkerD” p...
“Proteomics Managing Director, Dr Richard Lipscombe said: “PromarkerD works, it’s safe, and it can b...
“Proteomics International Laboratories (PIQ) reports its PromarkerD predictive test for diabetic kid...
“The results showed that patients predicted by PromarkerD to be at high-risk of chronic kidney disea...
“A BLOOD test to predict the onset of diabetic kidney disease up to four years in advance has been s...
“The Perth-based company that is no stranger to breaking new ground, is looking to complete the work...
“While both tests are aimed at faster diagnosis of COVID-19, each takes a different approach, with d...
“Proteomics International Laboratories, has received a $200,000 boost in funding courtesy of the WA ...
The Company has been awarded two grants under the Western Australian COVID-19 Research Grants Progra...
CE Mark registration received for the PromarkerD Immunoassay – the high-throughput version of the Pr...
“Proteomics International Laboratories (PIQ) has secured CE Mark registration for its PromarkerD Imm...
“Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, has secur...
“CE marking of the immunoassay kit will enable a greater number of prospective laboratories to proce...
The Company is pleased to provide the following market update on its expanding diagnostics developme...
Proteomics International is pleased to announce its collaboration with Janssen Research & Developmen...
Proteomics International has identified protein ‘fingerprints’ in the blood that could be used to te...
Newly identified biomarkers via the Promarker™ platform provide a breakthrough for Proteomics Intern...
Proteomics International’s Managing Director has been featured alongside the West Australian Ministe...
Proteomics International announces the attached presentation on PromarkerD (MS)# was given yesterday...
CE Mark registration received for the PromarkerD Hub – a software tool used to calculate the risk of...